Anzeige
Mehr »
Login
Freitag, 03.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
MAKING CRYPTO GREAT AGAIN: Wie Trumps Aussagen die Krypto-Landschaft verändern könnten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JCLB | ISIN: FR0011049824 | Ticker-Symbol: 4ZG
Frankfurt
02.01.25
20:36 Uhr
4,400 Euro
0,000
0,00 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDIAN TECHNOLOGIES Chart 1 Jahr
5-Tage-Chart
MEDIAN TECHNOLOGIES 5-Tage-Chart
RealtimeGeldBriefZeit
4,2154,32508:30

Aktuelle News zur MEDIAN TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.12.24Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2024194Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
26.11.24Median Technologies to Showcase AI-Powered Lung Cancer Diagnostic eyonis LCS at the Radiological Society of North America (RSNA) 202439Peer-reviewed scientific e-poster: "Performances of an End-to-End AI/ML CADe/CADx SaMD for Nodule Detection and Characterization in Lung Cancer Screening on an Independent Cohort Compared to Radiologists."...
► Artikel lesen
12.11.24Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2024232Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln
07.11.24Median Technologies Hosted Insightful Key Opinion Leader (KOL) Webinar on eyonis Lung Cancer Screening (LCS) REALITY Data307Two globally leading pulmonologists reviewed REALITY data, AI and the potential impact on lung cancer screening Replay in English is available on the link here A French subtitled...
► Artikel lesen
30.10.24Median Technologies to Host Key Opinion Leader (KOL) Webinar on AI and Lung Cancer Screening278Webinar to focus on the eyonis Lung Cancer Screening (LCS) REALITY data November 7, 2024 1:30 pm CET 7:30 am ET Registration link Regulatory News: Median Technologies (FR0011049824, ALMDT...
► Artikel lesen
24.10.24Median Technologies Reports 2024 Q3 Operational and Financial Update and 2024 Half-Year Results304eyonis LCS pivotal REALITY study met all primary and secondary endpoints A webcast including Key Opinion Leaders will be held on November 7, 2024, to discuss the REALITY study results ...
► Artikel lesen
07.10.24Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30th, 2024270Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares ...
► Artikel lesen
11.09.24Median Technologies to Attend and Present at the ESMO Congress 2024, Being Held in Barcelona, Spain, from Sept 13-17, 2024460Peer-reviewed scientific poster for eyonis LCS Median iCRO eyonis teams will be at booth #525, Exhibit Hall 3. Regulatory News: Median Technologies FR0011049824, ALMDT, PEA/SME eligible...
► Artikel lesen
06.09.24Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31st, 2024456Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
04.09.24Median Technologies to share positive pivotal data for eyonis LCS diagnostic software as medical device at the IASLC 2024 World Conference on Lung Cancer428(San Diego, CA, USA, from September 7-10, 2024) eyonis LCS is a proprietary Software as Medical Device (SaMD) powered by artificial intelligence (AI) machine learning (ML) for early detection...
► Artikel lesen
02.09.24Median Technologies to host two webcasts on September 5, 2024323eyonis LCS: New Horizons in Fighting Lung Cancer" Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "The Company") will host two live webcasts on September...
► Artikel lesen
29.08.24Median Technologies Announces Pivotal REALITY Study of Its eyonis LCS Lung Cancer Diagnostic Met All Primary and Secondary Endpoints271eyonis LCS met the primary endpoint for accuracy, achieving an Area Under the Curve (AUC)1 of 0.90, significantly above the 0.80 set for regulatory clearance. eyonis LCS met all 9 secondary...
► Artikel lesen
08.08.24Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31st, 2024265Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
06.08.24Median Technologies Partners with a Top 10 Oncology Pharma Company to Apply AI for Imaging Biomarker Discovery355The partnership's aim is to identify predictive imaging biomarkers of patient response to a specific drug-candidate, using Imaging Lab's unique AI capabilities. The company is a Top 10...
► Artikel lesen
18.07.24Median Technologies Reports Record iCRO Backlog, eyonis LCS On-Track for Standalone Pivotal Study Readout in August458As of June 30, 2024, order backlog at €71.7 million, an all-time high for Median. First major iCRO deals in Japan and South Korea. China sales recovering and bookings growth accelerating....
► Artikel lesen
11.07.24Median Technologies: Financial Communication Schedule for the Second Half of 2024464Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "the Company"), announces the publication date for its 2024 half year results and Q3, 2024 business activity:...
► Artikel lesen
05.07.24Half year Median Technologies liquidity contract statement386Regulatory News: Under the liquidity contract entrusted by Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "the Company") to TP ICAP (Europe), the following resources were...
► Artikel lesen
03.07.24Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30th, 2024260Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
07.06.24Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of May 31st, 2024609Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
03.06.24Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders' Ordinary and Extraordinary General Meeting on June 19, 2024261Regulatory News: The shareholders of Median Technologies FR0011049824, ALMDT, PEA/PME scheme eligible, "Median" or "The Company" are invited to participate in the Shareholders' Ordinary and Extraordinary...
► Artikel lesen
Seite:  Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1